deferoxamine has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holland, JP; Lewis, JS; May, C; McDevitt, MR; Ruggiero, A; Scheinberg, DA; Sprinkle, SR; Villa, CH | 1 |
| Abdel-Atti, D; Houghton, JL; Lewis, JS; Sawada, R; Scholz, WW; Zeglis, BM | 1 |
2 other study(ies) available for deferoxamine and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
| Article | Year |
|---|---|
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes.
Topics: Actinium; Adenocarcinoma; Animals; Cell Line, Tumor; Colonic Neoplasms; Deferoxamine; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Nude; Nanomedicine; Nanotubes, Carbon; Neovascularization, Pathologic; Positron-Emission Tomography; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Xenograft Model Antitumor Assays; Zirconium | 2010 |
Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.
Topics: Animals; Antibodies, Neoplasm; Antigens, Neoplasm; Cell Line, Tumor; Copper Radioisotopes; Deferoxamine; Heterocyclic Compounds, 1-Ring; Humans; Mice; Neoplasm Transplantation; Pancreatic Neoplasms; Positron-Emission Tomography; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Zirconium | 2016 |